DK0579363T3 - Behandling af tropisk spastisk parese med peptid T - Google Patents

Behandling af tropisk spastisk parese med peptid T

Info

Publication number
DK0579363T3
DK0579363T3 DK93303919T DK93303919T DK0579363T3 DK 0579363 T3 DK0579363 T3 DK 0579363T3 DK 93303919 T DK93303919 T DK 93303919T DK 93303919 T DK93303919 T DK 93303919T DK 0579363 T3 DK0579363 T3 DK 0579363T3
Authority
DK
Denmark
Prior art keywords
thr
amino
ser
residue
terminal residue
Prior art date
Application number
DK93303919T
Other languages
Danish (da)
English (en)
Inventor
Candace B Bert
Michael R Ruff
Original Assignee
Advanced Peptides & Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Peptides & Biotech filed Critical Advanced Peptides & Biotech
Application granted granted Critical
Publication of DK0579363T3 publication Critical patent/DK0579363T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK93303919T 1992-06-15 1993-05-20 Behandling af tropisk spastisk parese med peptid T DK0579363T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/898,691 US6242564B1 (en) 1986-06-03 1992-06-15 Treatment of tropical spastic paresis with peptide T

Publications (1)

Publication Number Publication Date
DK0579363T3 true DK0579363T3 (da) 2001-02-19

Family

ID=25409893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93303919T DK0579363T3 (da) 1992-06-15 1993-05-20 Behandling af tropisk spastisk parese med peptid T

Country Status (8)

Country Link
US (1) US6242564B1 (fr)
EP (1) EP0579363B1 (fr)
JP (1) JPH06247874A (fr)
AT (1) ATE198987T1 (fr)
AU (1) AU671989B2 (fr)
DE (1) DE69329899T2 (fr)
DK (1) DK0579363T3 (fr)
IL (1) IL105822A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5567682A (en) * 1988-12-16 1996-10-22 Advanced Peptides And Biotechnology Sciences Method of treating Alzheimer's disease
WO1995008339A1 (fr) * 1993-09-24 1995-03-30 Peptide Technology Limited Traitement ou prevention de la maladie de crohn et/ou de la colite ulcerative
WO1995008338A1 (fr) * 1993-09-24 1995-03-30 Peptide Technology Limited Methode de traitement de l'eczema et des dermatites
AUPM365794A0 (en) * 1994-02-02 1994-02-24 Minister for Agriculture & Rural Affairs for the State of NSW, The Biocontrol of take-all using phialophora sp. (lobed hyphopodia)
AU1979397A (en) * 1996-02-28 1997-09-16 Innapharma, Inc. Peptidomimetics for the treatment of hiv infection
JP2003528817A (ja) * 1999-11-09 2003-09-30 アドバンスド イムニ ティー インコーポレーティッド ペプチドｔ投与による前期遺伝子発現変更に基づくウィルス性疾患その他の疾病治療法
BRPI0611927A2 (pt) 2005-06-23 2011-08-16 Rapid Pharmaceuticals Ag composições terapêuticas
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
US20140322251A1 (en) 2013-04-26 2014-10-30 Michael Ruff Peptides for Progressive Treating Multi-Focal Leukoencephalopathy and Related Conditions
US10624944B2 (en) * 2017-06-19 2020-04-21 Creative Bio-Peptides Inc. Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
WO1987007614A1 (fr) * 1986-06-03 1987-12-17 Pert Candace B Petits peptides inhibant la liaison sur des recepteurs t-4 et agissant en tant qu'immunogenes
EP0249394B1 (fr) * 1986-06-03 1993-10-27 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Petits peptides qui inhibent la liaison avec les récepteurs T-4 et agissent comme immunogènes
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
WO1989012067A1 (fr) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Preparations utilises comme traitement du psoriasis et des deficits neuropsychiatriques
US5689398A (en) * 1996-01-03 1997-11-18 Allen-Bradley Company, Inc. Redundant control relay circuits

Also Published As

Publication number Publication date
IL105822A0 (en) 1993-09-22
DE69329899D1 (de) 2001-03-08
AU671989B2 (en) 1996-09-19
JPH06247874A (ja) 1994-09-06
DE69329899T2 (de) 2001-05-23
ATE198987T1 (de) 2001-02-15
EP0579363A1 (fr) 1994-01-19
EP0579363B1 (fr) 2001-01-31
IL105822A (en) 1999-11-30
AU3871993A (en) 1993-12-16
US6242564B1 (en) 2001-06-05

Similar Documents

Publication Publication Date Title
DK0579363T3 (da) Behandling af tropisk spastisk parese med peptid T
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
LU91166I2 (fr) Enfuvirtide, facultativement sous forme d'un sel ou ester pharmaceutiquement acceptable (FUZEON).
ATE154363T1 (de) Synthetische polypeptide als inhibitoren von hiv- 1
DE60329201D1 (de) Substituierte wt1-peptide
ES2075040T3 (es) 2',3'-dideoxi-2',2'-difluoronucleosidos.
ATE278708T1 (de) Conotoxin peptid pviia
DK0466174T3 (da) Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)
RU96104348A (ru) Профилактика спида
DK0573538T3 (da) Peptider til behandling
CA2334941A1 (fr) Peptides derives du tnf utilises dans le traitement des oedemes
ATE96450T1 (de) Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
FI925972A (fi) Ny polypeptid med affinitet till lipopolysackarider och dess anvaendning
DE3751398D1 (de) Substrat-Peptide.
ATE42308T1 (de) Pharmakologisch aktive peptide.
DE69117965D1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
CO4930283A1 (es) Analogos peptidos lh-rh, su empleo y composiciones farmaceu- ticas que los contienen
ATE92078T1 (de) Pharmakologisch aktive peptide.
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
CA1090784A (fr) Pepitides synthetiques
DK0426314T3 (da) HIV-relaterede peptider
ATE46173T1 (de) Pharmakologisch aktive peptide.
WO1994004565A3 (fr) Vaccin vnpi
WO1997025343A3 (fr) Agents antithrombotiques et procedes d'utilisation
ES2061497T3 (es) Peptidos cortos que inhiben la fijacion a receptores t-4 y actuan como inmunogenos.